Boothbay Fund Management, LLC Gamida Cell Ltd. Transaction History

Boothbay Fund Management, LLC

  • $3.6 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$5.85 - $8.33 $82,988 - $118,169
-14,186 Closed
0 $0
Q1 2021

May 17, 2021
SELL
$7.8 - $12.43 $177,910 - $283,515
-22,809 Reduced 61.65%
14,186 $115,000
Q4 2020

Feb 12, 2021
BUY
$4.07 - $11.0 $150,569 - $406,945
36,995 New
36,995 $310,000

About Gamida Cell Ltd.

GMDA Quotes by TradingView
  • Ticker GMDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,319,600
  • Market Cap $2.29M
  • Description
  • Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials ...
More about GMDA
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email